OncoDaily

OncoDaily Your daily dose of hope, inspiration, and information in the fight against cancer.

OncoDaily.com – your go-to destination for the latest news, insights, and patient stories from the world of oncology!

🤢 Could olanzapine improve nausea control during radiotherapy?A phase III trial found that adding low-dose olanzapine to...
09/05/2026

🤢 Could olanzapine improve nausea control during radiotherapy?

A phase III trial found that adding low-dose olanzapine to ondansetron significantly reduced radiation-induced nausea and vomiting in patients receiving abdominal or pelvic radiotherapy.

🔗 Read more in the comments.

🫁 Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLCNew clinical data highlight the potenti...
09/05/2026

🫁 Daraxonrasib Opens a Broader RAS-Targeting Strategy in Previously Treated NSCLC

New clinical data highlight the potential of daraxonrasib as a targeted treatment approach for patients with KRAS G12C-mutated non-small cell lung cancer.

🔗 Read more in the comments.

09/05/2026

Continue to be human | Ntizimira Christian Heritier

In this episode of World Health Voices on TV, Dr. Gevorg Tamamyan speaks with Dr. Christian Ntizimira, Founder and Executive Director of ACREOL-African Center for Research on End of Life Care, about the evolution of in Rwanda.

They discuss what palliative care truly means, the importance of changing perceptions, and efforts to strengthen research, education, advocacy, and integration into Rwanda’s public health system.

The full interview is available via the link in the comments.

Cancer screening changes with age and knowing when to start can make a difference. 🎗️Swipe through for a simple guide to...
09/05/2026

Cancer screening changes with age and knowing when to start can make a difference. 🎗️

Swipe through for a simple guide to the key screening milestones at every stage of adulthood.

Read more in the comments⬇️


🏆 A Proud Moment for OncoDailyWe are proud to announce that Dr. Gevorg Tamamyan, Co-Founder and Editor-in-Chief of OncoD...
09/05/2026

🏆 A Proud Moment for OncoDaily

We are proud to announce that Dr. Gevorg Tamamyan, Co-Founder and Editor-in-Chief of OncoDaily, has been selected for the 2026 Global Health Catalyst Distinguished Leader Award.

The award recognizes his contributions to global oncology, health equity, and international collaboration.

Congratulations, Dr. Tamamyan, on this well-deserved recognition👏

Read more in the comments.

Day 2 of LeukO 2026 is officially complete! 🩸 Today brought together global perspectives, patient advocacy, survivor voi...
09/05/2026

Day 2 of LeukO 2026 is officially complete! 🩸

Today brought together global perspectives, patient advocacy, survivor voices, and expert discussions from across the leukemia community.

Thank you to all of our speakers, moderators, and participants who made these two days so meaningful.

Read the full highlights in the comments.

FDA Approves Camizestrant for ESR1-Mutated Breast CancerThe approval marks a major step for ctDNA-guided treatment, allo...
09/04/2026

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The approval marks a major step for ctDNA-guided treatment, allowing therapy to change based on molecular resistance before radiographic progression.

🔗 Read more in the comments.

🎗️ Can genomic testing improve treatment decisions in early breast cancer?A large real-world analysis suggests that Onco...
09/04/2026

🎗️ Can genomic testing improve treatment decisions in early breast cancer?

A large real-world analysis suggests that Oncotype DX-guided chemotherapy decisions may be associated with more favorable overall survival in HR+/HER2− breast cancer.

🔗 Read more in the comments.

🩸 Arsenic Therapy in APL: A Treatment That Changed the LandscapeArsenic-based therapy has transformed the treatment of a...
09/04/2026

🩸 Arsenic Therapy in APL: A Treatment That Changed the Landscape

Arsenic-based therapy has transformed the treatment of acute promyelocytic leukemia (APL), becoming a cornerstone of modern care.

🔗 Read the full article in the comments.

09/04/2026

🎗️ September is Childhood Cancer Awareness Month.
This is a time to stand with children and families affected by cancer, raise awareness, support research, and advocate for better care.

The gold ribbon symbolizes the value of every child’s life and the hope for a future free from childhood cancer.

🔗 Read more on OncoDaily

Address

Boston, MA

Telephone

+19787174884

Website

Alerts

Be the first to know and let us send you an email when OncoDaily posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to OncoDaily:

Shortcuts

Share

Category